Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Could widespread use of antiviral treatment curb the COVID-19 pandemic? A modeling study

Fig. 1

Percentage of deaths averted for A Kenya, B Mexico, C United States and D Belgium. Percentage of deaths averted assuming an epidemic wave with parameters similar to those of the Omicron epidemic wave (transmissibility, vaccine effectiveness, and vaccination coverage) when compared to a baseline of no antiviral treatment. For each country, the colors represent four possible values of AVT (25, 50, 75 or 100% reduction in viral transmission in treated symptomatic individuals) and a daily treatment initiation rate (DTIR) of 2–100% of adult symptomatic individuals within the first 5 days of symptoms

Back to article page